Atluri Keerthi, Seabold Denise, Hong Liu, Elangovan Satheesh, Salem Aliasger K
†Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, The University of Iowa, Iowa City, Iowa 52242, United States.
‡Department of Periodontics, College of Dentistry, The University of Iowa, Iowa City, Iowa 52242, United States.
Mol Pharm. 2015 Aug 3;12(8):3032-42. doi: 10.1021/acs.molpharmaceut.5b00297. Epub 2015 Jul 10.
This study highlights the importance of transfection mediated coordinated bone morphogenetic protein 2 (BMP-2) and fibroblast growth factor 2 (FGF-2) signaling in promoting osteogenesis. We employed plasmids independently encoding BMP-2 and FGF-2 complexed with polyethylenimine (PEI) to transfect human adipose derived mesenchymal stem cells (hADMSCs) in vitro. The nanoplexes were characterized for size, surface charge, in vitro cytotoxicity, and transfection ability in hADMSCs. A significant enhancement in BMP-2 protein secretion was observed on day 7 post-transfection of hADMSCs with PEI nanoplexes loaded with both pFGF-2 and pBMP-2 (PEI/(pFGF-2+pBMP-2)) versus transfection with PEI nanoplexes of either pFGF-2 alone or pBMP-2 alone. Osteogenic differentiation of transfected hADMSCs was determined by measuring osteocalcin and Runx-2 gene expression using real time polymerase chain reactions. A significant increase in the expression of Runx-2 and osteocalcin was observed on day 3 and day 7 post-transfection, respectively, by cells transfected with PEI/(pFGF-2+pBMP-2) compared to cells transfected with nanoplexes containing pFGF-2 or pBMP-2 alone. Alizarin Red staining and atomic absorption spectroscopy revealed elevated levels of calcium deposition in hADMSC cultures on day 14 and day 30 post-transfection with PEI/(pFGF-2+pBMP-2) compared to other treatments. We have shown that codelivery of pFGF-2 and pBMP-2 results in a significant enhancement in osteogenic protein synthesis, osteogenic marker expression, and subsequent mineralization. This research points to a new clinically translatable strategy for achieving efficient bone regeneration.
本研究强调了转染介导的骨形态发生蛋白2(BMP-2)和成纤维细胞生长因子2(FGF-2)信号协同作用在促进成骨过程中的重要性。我们使用独立编码BMP-2和FGF-2并与聚乙烯亚胺(PEI)复合的质粒在体外转染人脂肪来源间充质干细胞(hADMSCs)。对纳米复合物的大小、表面电荷、体外细胞毒性以及在hADMSCs中的转染能力进行了表征。与单独用PEI纳米复合物转染pFGF-2或pBMP-2相比,用负载有pFGF-2和pBMP-2的PEI纳米复合物(PEI/(pFGF-2 + pBMP-2))转染hADMSCs后第7天,观察到BMP-2蛋白分泌显著增强。通过实时聚合酶链反应测量骨钙素和Runx-2基因表达,确定转染的hADMSCs的成骨分化情况。与单独用含有pFGF-2或pBMP-2的纳米复合物转染的细胞相比,用PEI/(pFGF-2 + pBMP-2)转染的细胞在转染后第3天和第7天分别观察到Runx-2和骨钙素表达显著增加。茜素红染色和原子吸收光谱显示,与其他处理相比,用PEI/(pFGF-2 + pBMP-2)转染后第14天和第30天,hADMSC培养物中的钙沉积水平升高。我们已经表明,pFGF-2和pBMP-2的共递送导致成骨蛋白合成、成骨标志物表达以及随后的矿化显著增强。这项研究指出了一种实现高效骨再生的新的临床可转化策略。